| 000 | 01619 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513100115.0 | ||
| 264 | 0 | _c19961120 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0720-048X | ||
| 024 | 7 |
_a10.1016/0720-048x(96)00742-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchweizer, J | |
| 245 | 0 | 0 |
_aComparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions. _h[electronic resource] |
| 260 |
_bEuropean journal of radiology _cMay 1996 |
||
| 300 |
_a129-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intra-Arterial |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeripheral Vascular Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aPlasminogen Activators _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xmethods |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xtherapeutic use |
| 700 | 1 | _aAltmann, E | |
| 700 | 1 | _aStösslein, F | |
| 700 | 1 | _aFlorek, H J | |
| 700 | 1 | _aKaulen, R | |
| 773 | 0 |
_tEuropean journal of radiology _gvol. 22 _gno. 2 _gp. 129-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0720-048x(96)00742-5 _zAvailable from publisher's website |
| 999 |
_c8789852 _d8789852 |
||